Emerging cardiovascular indications of mineralocorticoid receptor antagonists
Author:
Publisher
Elsevier BV
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference74 articles.
1. Mineralocorticoid receptors: distribution and activation;Funder;Heart Fail. Rev.,2005
2. Mechanisms of mineralocorticoid action;Fuller;Hypertension,2005
3. A comparison of the aldosterone-blocking agents eplerenone and spironolactone;Struthers;Clin. Cardiol.,2008
4. Selection of a mineralocorticoid receptor antagonist for patients with hypertension or heart failure;Iqbal;Eur. J. Heart Fail.,2014
5. A new mode of mineralocorticoid receptor antagonism by a potent and selective nonsteroidal molecule;Fagart;J. Biol. Chem.,2010
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Implications of Atrial Fibrillation for Guideline-Directed Therapy in Patients With Heart Failure;Journal of the American College of Cardiology;2024-03
2. Association between Use of Spironolactone and Risk of Stroke in Hypertensive Patients: A Cohort Study;Pharmaceuticals;2022-12-30
3. Potassium Concentrations in Transgender Women Using Spironolactone: A Retrospective Chart Review;Endocrine Practice;2022-11
4. Effects of Finerenone Combined with Empagliflozin in a Model of Hypertension-Induced End-Organ Damage;American Journal of Nephrology;2021
5. The consequence of biomarkers of myocardial fibrosis in the prediction of arrhythmias in patients with hypertension in combination with coronary heart disease (literature review);Medicni perspektivi (Medical perspectives);2020-12-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3